MSN LABS PVT LTD FDA Approval ANDA 212625

ANDA 212625

MSN LABS PVT LTD

FDA Drug Application

Application #212625

Documents

Letter2021-03-10

Application Sponsors

ANDA 212625MSN LABS PVT LTD

Marketing Status

None (Tentative Approval)001
None (Tentative Approval)002

Application Products

001UNKNOWNUNKNOWN0NALOXEGOLNALOXEGOL
002TABLET;ORAL25MG0NALOXEGOLNALOXEGOL

FDA Submissions

UNKNOWN; ORIG1TA2021-02-24STANDARD

Submissions Property Types

ORIG1Null31

CDER Filings

MSN LABS PVT LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 212625
            [companyName] => MSN LABS PVT LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"NALOXEGOL","activeIngredients":"NALOXEGOL","strength":"UNKNOWN","dosageForm":"UNKNOWN","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"02\/24\/2021","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-02-24
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.